Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 81 Neoplasms, Plasma Cell 27 Neoplasms 13 Brain Neoplasms 11 Prostatic Neoplasms 10 Central Nervous System Neoplasms 10 Melanoma 9 Leukemia 9 Glioblastoma 8 Gliosarcoma 7 Glioma 7 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Hepatocellular 6 Recurrence 5 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Lymphoma, Mantle-Cell 5 Lung Neoplasms 5 Waldenstrom Macroglobulinemia 4 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4 Immunoglobulin Light-chain Amyloidosis 4 Carcinoma, Renal Cell 4 Uveal Melanoma 3 Oligodendroglioma 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3

Interventions

Lidocaine 4 Oxycodone 2 Capsaicin 2 ziconotide 1 nabiximols 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Transcranial Magnetic Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Surveys and Questionnaires 1 Sodium Chloride 1 Pregabalin 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Manipulation, Osteopathic 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hypnosis 1 Hydromorphone 1 Geritol 1 Gabapentin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuralgia × Thalidomide × Clear all

NCT00284505 2008-12-05

Use of Thalidomide in Patients With Arachnoiditis

Washington University School of Medicine

Phase 2 Completed

Arachnoiditis, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡